Comorbid insomnia and sleep apnoea is associated with all-cause mortality.

BACKGROUND

Increased mortality has been reported in people with insomnia and in those with obstructive sleep apnoea (OSA). However, these conditions commonly co-occur and the combined effect of comorbid insomnia and sleep apnoea (COMISA) on mortality risk is unknown. This study used Sleep Heart Health Study (SHHS) data to assess associations between COMISA and all-cause mortality risk.

METHODS

Insomnia was defined as difficulties falling asleep, maintaining sleep and/or early morning awakenings from sleep ≥16 times per month, and daytime impairments. OSA was defined as an apnoea-hypopnoea index ≥15 events·h

RESULTS

5236 participants were included. 2708 (52%) did not have insomnia/OSA (reference group), 170 (3%) had insomnia-alone, 2221 (42%) had OSA-alone and 137 (3%) had COMISA. COMISA participants had a higher prevalence of hypertension (OR 2.00, 95% CI 1.39-2.90) and cardiovascular disease (CVD) (OR 1.70, 95% CI 1.11-2.61) compared with the reference group. Insomnia-alone and OSA-alone were associated with higher risk of hypertension but not CVD compared with the reference group. Compared with the reference group, COMISA was associated with a 47% (hazard ratio 1.47, 95% CI 1.06-2.07) increased risk of mortality. The association between COMISA and mortality was consistent across multiple definitions of OSA and insomnia.

CONCLUSIONS

COMISA was associated with higher rates of hypertension and CVD at baseline, and an increased risk of all-cause mortality compared with no insomnia/OSA.

Informations de copyright

Copyright ©The authors 2022. For reproduction rights and permissions contact [e-mail].

Déclaration de conflit d'intérêts

Conflict of interest: B. Lechat has nothing to disclose. Conflict of interest: S. Appleton has nothing to disclose. Conflict of interest: Y.A. Melaku has nothing to disclose. Conflict of interest: K. Hansen reports grants from the Australian Research Council, during the conduct of the study. Conflict of interest: R.D. McEvoy reports grants from the National Health and Medical Research Council, during the conduct of the study. Conflict of interest: R. Adams reports grants from The Hospital Research Foundation, National Health and Medical Research Council, ResMed Foundation, Phillips Foundation and Sleep Health Foundation, during the conduct of the study. Conflict of interest: P. Catcheside reports grants from the National Health and Medical Research Council, Defence Science and Technology, and the Flinders Foundation, outside the submitted work. Conflict of interest: L. Lack reports grants, personal fees and nonfinancial support from Re-time Pty Ltd, outside the submitted work. Conflict of interest: D.J. Eckert reports grants from the National Health and Medical Research Council of Australia, during the conduct of the study; grants and personal fees from Apnimed, and Bayer, grants from the Collaborative Research Centre (CRC-P), outside the submitted work; and has a patent “Methods for estimating key phenotypic traits for obstructive sleep apnoea and simplified clinical tools to direct targeted therapy”, PCT patent application pending. Conflict of interest: A. Sweetman has nothing to disclose.